Amgen Inc (AMGN)
289.70
+1.83
(+0.64%)
USD |
NASDAQ |
Nov 21, 15:51
Amgen Profit Margin (Quarterly): 33.28% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 33.28% |
| June 30, 2024 | 8.89% |
| March 31, 2024 | -1.52% |
| December 31, 2023 | 9.36% |
| September 30, 2023 | 25.06% |
| June 30, 2023 | 19.74% |
| March 31, 2023 | 46.54% |
| December 31, 2022 | 23.63% |
| September 30, 2022 | 32.22% |
| June 30, 2022 | 19.97% |
| March 31, 2022 | 23.66% |
| December 31, 2021 | 27.74% |
| September 30, 2021 | 28.09% |
| June 30, 2021 | 7.11% |
| March 31, 2021 | 27.89% |
| December 31, 2020 | 24.34% |
| September 30, 2020 | 31.46% |
| June 30, 2020 | 29.05% |
| March 31, 2020 | 29.62% |
| December 31, 2019 | 27.48% |
| September 30, 2019 | 34.30% |
| June 30, 2019 | 37.11% |
| March 31, 2019 | 35.85% |
| December 31, 2018 | 30.95% |
| September 30, 2018 | 31.49% |
| Date | Value |
|---|---|
| June 30, 2018 | 37.89% |
| March 31, 2018 | 41.61% |
| December 31, 2017 | -73.49% |
| September 30, 2017 | 35.01% |
| June 30, 2017 | 37.02% |
| March 31, 2017 | 37.90% |
| December 31, 2016 | 32.44% |
| September 30, 2016 | 34.71% |
| June 30, 2016 | 32.88% |
| March 31, 2016 | 34.38% |
| December 31, 2015 | 32.51% |
| September 30, 2015 | 32.55% |
| June 30, 2015 | 30.78% |
| March 31, 2015 | 32.25% |
| December 31, 2014 | 24.27% |
| September 30, 2014 | 24.73% |
| June 30, 2014 | 29.86% |
| March 31, 2014 | 23.73% |
| December 31, 2013 | 20.38% |
| September 30, 2013 | 28.81% |
| June 30, 2013 | 26.89% |
| March 31, 2013 | 33.84% |
| December 31, 2012 | 17.82% |
| September 30, 2012 | 25.63% |
| June 30, 2012 | 28.28% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.52%
Minimum
Mar 2024
46.54%
Maximum
Mar 2023
23.68%
Average
26.27%
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 11.99% |
| Eli Lilly and Co | 8.48% |
| Merck & Co Inc | 18.95% |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Viking Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 65.35% |
| Return on Assets | 4.57% |
| Return on Invested Capital | 6.14% |
| Gross Profit Margin (Quarterly) | 61.07% |
| Operating Margin (Quarterly) | 24.07% |
| Return on Net Operating Assets | 6.38% |